These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 17114950)

  • 21. [Drugs against alcohol abuse].
    Mørland J
    Tidsskr Nor Laegeforen; 2006 Dec; 126(24):3268-9. PubMed ID: 17170774
    [No Abstract]   [Full Text] [Related]  

  • 22. Recent developments in the pharmacotherapy of alcohol dependence.
    Schuckit MA
    J Consult Clin Psychol; 1996 Aug; 64(4):669-76. PubMed ID: 8803356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy for Adults with Alcohol Use Disorder.
    Salisbury-Afshar E
    Am Fam Physician; 2016 Jul; 94(2):155-7. PubMed ID: 27419333
    [No Abstract]   [Full Text] [Related]  

  • 24. Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment.
    Mason BJ
    Eur Neuropsychopharmacol; 2003 Dec; 13(6):469-75. PubMed ID: 14636963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Medical treatment of alcohol dependence].
    Gache P; Siegrist G
    Rev Med Suisse Romande; 1998 Sep; 118(9):767-9. PubMed ID: 9810190
    [No Abstract]   [Full Text] [Related]  

  • 26. Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland.
    Buri C; Moggi F; Giovanoli A; Strik W
    Alcohol Alcohol; 2007; 42(4):333-9. PubMed ID: 17517820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacotherapy for alcohol dependence: anticraving medications for relapse prevention.
    Jung YC; Namkoong K
    Yonsei Med J; 2006 Apr; 47(2):167-78. PubMed ID: 16642544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rationale for combining acamprosate and naltrexone for treating alcohol dependence.
    Mason BJ
    J Stud Alcohol Suppl; 2005 Jul; (15):148-56; discussion 140. PubMed ID: 16223066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapies for alcoholism: the old and the new.
    Olive MF
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):2-4. PubMed ID: 20232494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1.
    Kenna GA; McGeary JE; Swift RM
    Am J Health Syst Pharm; 2004 Nov; 61(21):2272-9. PubMed ID: 15552634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials.
    Snyder JL; Bowers TG
    Am J Drug Alcohol Abuse; 2008; 34(4):449-61. PubMed ID: 18584575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in the pharmacotherapy of alcoholism.
    Myrick H; Anton R
    Curr Psychiatry Rep; 2004 Oct; 6(5):332-8. PubMed ID: 15355755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A longitudinal examination of alcohol pharmacotherapy adoption in substance use disorder treatment programs: patterns of sustainability and discontinuation.
    Abraham AJ; Knudsen HK; Roman PM
    J Stud Alcohol Drugs; 2011 Jul; 72(4):669-77. PubMed ID: 21683049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acamprosate and naltrexone: similar efficacy for relapse].
    Saitz R
    Rev Med Suisse; 2014 Dec; 10(455):2437. PubMed ID: 25752019
    [No Abstract]   [Full Text] [Related]  

  • 35. Medical treatment of alcohol dependence: a systematic review.
    Miller PM; Book SW; Stewart SH
    Int J Psychiatry Med; 2011; 42(3):227-66. PubMed ID: 22439295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Good effect of drug therapy against alcoholism].
    Söderpalm B
    Lakartidningen; 2011 Oct 9-15; 108(45):2285-9. PubMed ID: 22242243
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.
    Bouza C; Angeles M; Muñoz A; Amate JM
    Addiction; 2004 Jul; 99(7):811-28. PubMed ID: 15200577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neurobiological mechanisms and pharmacological treatment options for alcohol craving].
    Hillemacher T; Kornhuber J; Bleich S
    Fortschr Neurol Psychiatr; 2007 Jan; 75(1):26-32. PubMed ID: 17031777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of acamprosate and opioid antagonists in the treatment of alcohol dependence: a European perspective.
    Soyka M; Chick J
    Am J Addict; 2003; 12(s1):s69-s80. PubMed ID: 14972781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Group management of pharmacotherapy for alcohol dependence: feasibility and impact on adoption.
    Robinson S; Bowe T; Harris AH
    J Subst Abuse Treat; 2013; 45(5):475-7. PubMed ID: 23932227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.